Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study-Reference-Cited by-同舟云学术

Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study

Published:2012-03-05 Issue:6 Volume:12 Page:1528-1540
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Budde K.,Lehner F.,Sommerer C.,Arns W.,Reinke P.,Eisenberger U.,Wüthrich R. P.,Scheidl S.,May C.,Paulus E.-M.,Mühlfeld A.,Wolters H. H.,Pressmar K.,Stahl R.,Witzke O.,

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2012.03994.x/fullpdf

Reference36 articles.

1. Impact of cyclosporine on the development of immunosuppressive therapy;Fritsche;Transplant Proc,2004

2. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology;Nankivell;Transplantation,2004

3. Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection;Marcén;Drugs,2009

4. Effect of immunosuppressive agents on long-term survival of renal transplant recipients: Focus on the cardiovascular risk;Boots;Drugs,2004

5. Immunosuppressive therapy and malignancy in organ transplant recipients: A systematic review;Gutierrez-Dalmau;Drugs,2007

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation;Asian Biomedicine;2024-06-01

2. Calcineurin-inhibitor free immunosuppression after lung transplantation – a single center case-control study in 51 patients converted to Mechanistic Target of Rapamycin (mTOR) inhibitors;PLOS ONE;2023-05-18

3. Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation;Transplantation Proceedings;2023-05

4. Medical Aspects of mTOR Inhibition in Kidney Transplantation;International Journal of Molecular Sciences;2022-07-12

5. Cytomegalovirus en transplantation rénale : traitement préventif ou préemptif et nouvelles alternatives;Option/Bio;2021-11